Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Neuroscience
|
May 1, 1994
Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody IG2 in the rat cerebrum
A Oohira, F Matsui, E Watanabe, et al.
Hearing Research
|
August 1, 1997
Immunohistochemical localization of neurocan in the lower auditory nuclei of the dog
Y Atoji, Y Yamamoto, Y Suzuki, et al.
Journal of Pharmaceutical Sciences
|
January 1, 1985
Determination of hydrazine in pharmaceuticals IV: Hydrazine and benzylhydrazine in isocarboxazid
E G Lovering, F Matsui, D Robertson, et al.
The Journal of Biological Chemistry
|
July 25, 1988
Occurrence of three distinct molecular species of chondroitin sulfate proteoglycan in the developing rat brain
A Oohira, F Matsui, M Matsuda, et al.
Neuroscience Research
|
May 1, 1993
Biochemical comparison of brain glycosaminoglycans between normal and reeler mutant mice
F Matsui, A Oohira, R Shoji, et al.
Physical Review Letters
|
September 16, 2000
Reinterpretation of the molecular O2 chemisorbate in the initial oxidation of the si(111)7 x 7 surface
F Matsui, H W Yeom, K Amemiya, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1978
Impurities in drugs II: meperidine and its formulations
K M McErlane, R J Wood, F Matsui, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1972
Rapid GLC quantitation of salicylic acid in multicomponent codeine and propoxyphene analgesic formulations
J R Watson, F Matsui, P M McConnell, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1983
Determination of azobenzene and hydrazobenzene in phenylbutazone and sulfinpyrazone products by high-performance liquid chromatography
F Matsui, E G Lovering, N M Curran, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1980
Identification of degradation products in a phenylbutazone tablet formulation
F Matsui, D L Robertson, M A Poirier, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Neuroscience
|
May 1, 1994
Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody IG2 in the rat cerebrum
A Oohira, F Matsui, E Watanabe, et al.
Hearing Research
|
August 1, 1997
Immunohistochemical localization of neurocan in the lower auditory nuclei of the dog
Y Atoji, Y Yamamoto, Y Suzuki, et al.
Journal of Pharmaceutical Sciences
|
January 1, 1985
Determination of hydrazine in pharmaceuticals IV: Hydrazine and benzylhydrazine in isocarboxazid
E G Lovering, F Matsui, D Robertson, et al.
The Journal of Biological Chemistry
|
July 25, 1988
Occurrence of three distinct molecular species of chondroitin sulfate proteoglycan in the developing rat brain
A Oohira, F Matsui, M Matsuda, et al.
Neuroscience Research
|
May 1, 1993
Biochemical comparison of brain glycosaminoglycans between normal and reeler mutant mice
F Matsui, A Oohira, R Shoji, et al.
Physical Review Letters
|
September 16, 2000
Reinterpretation of the molecular O2 chemisorbate in the initial oxidation of the si(111)7 x 7 surface
F Matsui, H W Yeom, K Amemiya, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1978
Impurities in drugs II: meperidine and its formulations
K M McErlane, R J Wood, F Matsui, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1972
Rapid GLC quantitation of salicylic acid in multicomponent codeine and propoxyphene analgesic formulations
J R Watson, F Matsui, P M McConnell, et al.
Journal of Pharmaceutical Sciences
|
October 1, 1983
Determination of azobenzene and hydrazobenzene in phenylbutazone and sulfinpyrazone products by high-performance liquid chromatography
F Matsui, E G Lovering, N M Curran, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1980
Identification of degradation products in a phenylbutazone tablet formulation
F Matsui, D L Robertson, M A Poirier, et al.
Page
of 6